Golden Gate Capital
Private equity
Active
San Francisco, United States
20
111M
18
0.91
4
0.10
6
- Stages of investment
- Areas of investment
Summary
In 2000 was created Golden Gate Capital, which is appeared as VC. The leading representative office of defined VC is situated in the San Francisco. The fund was located in North America if to be more exact in United States.
For fund there is a match between the location of its establishment and the land of its numerous investments - United States. We can highlight the next thriving fund investment areas, such as Pharmaceutical, Medical Device. Among the most popular portfolio startups of the fund, we may highlight Infor, Infinium Labs, Itamar Medical. The fund has no specific favorite in a number of founders of portfolio startups. Besides, a startup needs to be aged 6-10 years to get the investment from the fund.
The typical case for the fund is to invest in rounds with 3 participants. Despite the Golden Gate Capital, startups are often financed by Viola Growth, Trilogy Equity Partners, Summit Partners. The meaningful sponsors for the fund in investment in the same round are West Elk Partners, Versant Ventures, Thoma Cressey Equity Partners. In the next rounds fund is usually obtained by Koch Equity Development, Longitude Capital.
Speaking about the real fund results, this VC is 5 percentage points more often commits exit comparing to other organizations. The increased amount of exits for fund were in 2007. Opposing the other organizations, this Golden Gate Capital works on 9 percentage points more the average amount of lead investments. The top activity for fund was in 2019. When the investment is from Golden Gate Capital the average startup value is more than 1 billion dollars. The fund is constantly included in less than 2 deals per year. The usual things for fund are deals in the range of more than 100 millions dollars.
We also calculated 9 valuable employees in our database.
Investor highlights
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Analytics
- Total investments
- 20
- Lead investments
- 4
- Exits
- 6
- Rounds per year
- 0.91
- Follow on index
- 0.10
- Investments by industry
- Software (3)
- Health Care (3)
- Insurance (3)
- Mining (2)
- Precious Metals (2) Show 38 more
- Investments by region
-
- United States (15)
- India (1)
- Israel (1)
- Peak activity year
- 2019
- Number of Minotaurs
- 1
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 18
- Avg. valuation at time of investment
- 21M
- Group Appearance index
- 0.40
- Avg. company exit year
- 12
- Avg. multiplicator
- 12.14
- Strategy success index
- 0.10
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Jazz Pharmaceuticals | 24 Mar 2004 | Biotechnology, Health Care, Pharmaceutical | Early Stage Venture | 250M | United States, California, Palo Alto |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.